Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2022
Factors Associated with Long Covid Symptoms in an Online Cohort Study
Matthew S Durstenfeld, Michael J Peluso, Noah D Peyser, et al.
ACS Infectious Diseases
|
May 10, 2023
Screen for New Antimicrobial Natural Products from the NCI Program for Natural Product Discovery Prefractionated Extract Library
Lucero Martínez-Fructuoso, S J Ryan Arends, Vitor F Freire, et al.
Plos One
|
February 6, 2024
Factors associated with anxiety during the first two years of the COVID-19 pandemic in the United States: An analysis of the COVID-19 Citizen Science study
Aaron E Cozen, Thomas Carton, Rita Hamad, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Positive Selection Screen for Natural Product β-Catenin Inactivators
Matthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
JAMA Network Open
|
October 16, 2024
Patient-Reported Outcomes Among Adults With Congenital Heart Disease in the Congenital Heart Initiative Registry
Scott Leezer, Rittal Mehta, Anushree Agarwal, et al.
BMC Public Health
|
October 10, 2022
The U.S. COVID-19 County Policy Database: a novel resource to support pandemic-related research
Rita Hamad, Kristin A Lyman, Feng Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 8, 2014
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer
Vivian Wai Yan Lui, Noah D Peyser, Patrick Kwok-Shing Ng, et al.
The Journal of Experimental Medicine
|
January 27, 2019
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer
Matthew L Hedberg, Noah D Peyser, Julie E Bauman, et al.
Cancer Discovery
|
April 27, 2013
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers
Vivian W Y Lui, Matthew L Hedberg, Hua Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2022
Factors Associated with Long Covid Symptoms in an Online Cohort Study
Matthew S Durstenfeld, Michael J Peluso, Noah D Peyser, et al.
ACS Infectious Diseases
|
May 10, 2023
Screen for New Antimicrobial Natural Products from the NCI Program for Natural Product Discovery Prefractionated Extract Library
Lucero Martínez-Fructuoso, S J Ryan Arends, Vitor F Freire, et al.
Plos One
|
February 6, 2024
Factors associated with anxiety during the first two years of the COVID-19 pandemic in the United States: An analysis of the COVID-19 Citizen Science study
Aaron E Cozen, Thomas Carton, Rita Hamad, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Positive Selection Screen for Natural Product β-Catenin Inactivators
Matthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
JAMA Network Open
|
October 16, 2024
Patient-Reported Outcomes Among Adults With Congenital Heart Disease in the Congenital Heart Initiative Registry
Scott Leezer, Rittal Mehta, Anushree Agarwal, et al.
BMC Public Health
|
October 10, 2022
The U.S. COVID-19 County Policy Database: a novel resource to support pandemic-related research
Rita Hamad, Kristin A Lyman, Feng Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 8, 2014
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer
Vivian Wai Yan Lui, Noah D Peyser, Patrick Kwok-Shing Ng, et al.
The Journal of Experimental Medicine
|
January 27, 2019
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer
Matthew L Hedberg, Noah D Peyser, Julie E Bauman, et al.
Cancer Discovery
|
April 27, 2013
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers
Vivian W Y Lui, Matthew L Hedberg, Hua Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Page
of 6